Geode Capital Management, LLC Neuro Sense Therapeutics Ltd. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 11,963 shares of NRSN stock, worth $10,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,963
Previous 11,963
-0.0%
Holding current value
$10,168
Previous $9,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
167KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny71.1KShares$60,4350.0% of portfolio
-
Meitav Dash Investments LTD50KShares$42,5000.0% of portfolio
-
Woodline Partners LP San Francisco, CA19.6KShares$16,6430.0% of portfolio
-
Ubs Group Ag11.9KShares$10,1380.0% of portfolio
-
Morgan Stanley New York, NY1.5KShares$1,2750.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $9.92M